360° real-time visibility into companies, pipelines, financials, deals, leadership, and regulatory moves. BIO 360 continuously analyzes thousands of sources and turns fragmented signals into actionable intelligence.
Profiles of pharma, biotech, CDMOs, and startups — segments, footprint, platforms, pipeline.
Revenue, cash runway, and burn rate with AI early-warning signals for cash and revenue risk.
Full-lifecycle pipeline tracking across modalities, milestones, and endpoints.
Licensing, M&A, and collaborations with value, milestone, and royalty analytics.
Real-time leadership tracking plus signals that flag distressed assets.
Monitors filings, earnings calls, and disclosures, classifying competitive threats.
Profiles of pharma, biotech, CDMOs, and startups — segments, footprint, platforms, pipeline.
Revenue, cash runway, and burn rate with AI early-warning signals for cash and revenue risk.
Full-lifecycle pipeline tracking across modalities, milestones, and endpoints.
Licensing, M&A, and collaborations with value, milestone, and royalty analytics.
Real-time leadership tracking plus signals that flag distressed assets.
Monitors filings, earnings calls, and disclosures, classifying competitive threats.
Financial-health model trained on biopharma-specific burn-rate and runway patterns — not generic fintech signals.
Watchlists and alert thresholds customisable per team and therapeutic focus.
Pipeline data sourced and curated daily, not scraped quarterly.
Deal terms and asset-level structuring captured, not just announcement headlines.
Natural-language questions BIO 360 answers in seconds:
Book a walkthrough with the right specialist and we'll tailor it to your therapeutic area and the questions your team is asking.
